EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Volume 210 / Numéro 4 (2016) Biologie Aujourd'hui, 210 4 (2016) 171-189 References
Free Access
Issue
Biologie Aujourd'hui
Volume 210, Number 4, 2016
Page(s) 171 - 189
Section Hypertension artérielle pulmonaire : une avancée thérapeutique
DOI https://doi.org/10.1051/jbio/2016022
Published online 22 mars 2017
  • Abdul, M., Hoosein, N. (2005). N-methyl-D-aspartate receptor in human prostate cancer. J Membr Biol, 205, 125-128. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Affaticati, P., Mignen, O., Jambou, F., Potier, M.-C., Klingel-Schmitt, I., Degrouard, J., Peineau, S., Gouadon, E., Collingridge, G.L., Liblau, R., Capiod, T., Cohen-Kaminsky, S. (2011). Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells. Cell Death Differ, 18, 99-108. [EDP Sciences] [PubMed] [Google Scholar]
  • Aldred, M.A., Comhair, S.A., Varella-Garcia, M., Asosingh, K., Xu, W., Noon G.P.,.Thistlethwaite, P.A., Tuder, R.M., Erzurum, S.C., Geraci, M.W., Coldren, C.D. (2010). Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension. Am J Respir Crit Care Med, 182, 1153-1160. [CrossRef] [PubMed] [Google Scholar]
  • Ali, S., Shourideh, M., Koochekpour, S. (2014). Identification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer cell lines and tissues. PloS One, 9, e103204. [PubMed] [Google Scholar]
  • András, I.E., Deli, M.A., Veszelka, S., Hayashi, K., Hennig, B., Toborek, M. (2007). The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab, 27, 1431-1443. [CrossRef] [PubMed] [Google Scholar]
  • Aronica, E., Yankaya, B., Jansen, G.H., Leenstra, S., van Veelen, C.W., Gorter, J.A., Troost, D. (2001). Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol Appl Neurobiol, 27, 223-237. [PubMed] [Google Scholar]
  • Bai, L., Zhang, X., Ghishan, F.K. (2003). Characterization of vesicular glutamate transporter in pancreatic alpha- and beta-cells and its regulation by glucose. Am J Physiol Gastrointest Liver Physiol, 284, G808-G814. [PubMed] [Google Scholar]
  • Bertero, T., Oldham, W.M., Cottrill, K.A., Pisano, S., Vanderpool, R.R., Yu, Q., Zhao, J., Tai, Y., Tang, Y., Zhang, Y.-Y., Rehman, S., Sugahara, M., Qi, Z., Gorcsan, J., Vargas, S.O., Saggar, R., Saggar, R., Wallace, W.D., Ross, D.J., Haley, K.J., Waxman, A.B., Parikh, V.N., De Marco, T., Hsue, P.Y., Morris, A., Simon, M.A., Norris, K.A., Gaggioli, C., Loscalzo, J., Fessel, J., Chan, S.Y. (2016). Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J Clin Invest, 126, 3313-3335. [PubMed] [Google Scholar]
  • Bhangu, P.S., Genever, P.G., Spencer, G.J., Grewal, T.S., Skerry, T.M. (2001). Evidence for targeted vesicular glutamate exocytosis in osteoblasts. Bone, 29, 16-23. [CrossRef] [PubMed] [Google Scholar]
  • Bussone, G., Tamby, M.C., Calzas, C., Kherbeck, N., Sahbatou, Y., Sanson, C., Ghazal, K., Dib, H., Weksler, B.B., Broussard, C., Verrecchia, F., Yaici, A., Witko-Sarsat, V., Simonneau, G., Guillevin, L., Humbert, M., Mouthon, L. (2012). IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction. Ann Rheum Dis, 71, 596-605. [CrossRef] [PubMed] [Google Scholar]
  • Cacoub, P., Dorent, R., Maistre, G., Nataf, P., Carayon, A., Piette, C., Godeau, P., Cabrol, C., Gandjbakhch, I. (1993). Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol, 71, 448-450. [CrossRef] [PubMed] [Google Scholar]
  • Casado, M., López-Guajardo, A., Mellström, B., Naranjo, J.R., Lerma, J. (1996). Functional N-methyl-D-aspartate receptors in clonal rat phaeochromocytoma cells. J Physiol, 490, 391-404. [CrossRef] [PubMed] [Google Scholar]
  • Chang, H.J., Yoo, B.C., Lim, S.-B., Jeong, S.-Y., Kim, W.H., Park, J.-G. (2005). Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res, 11, 3288-3295. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Chaumais, M.-C., Guignabert, C., Savale, L., Jaïs, X., Boucly, A., Montani D., Simonneau, G., Humbert, M., Sitbon, O. (2015). Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension. Am J Cardiovasc Drugs, 15, 13-26. [CrossRef] [PubMed] [Google Scholar]
  • Choi, C.H., Choi, J.-J., Park, Y.-A., Lee, Y.-Y., Song, S.Y., Sung, C.O., Song, T., Kim, M.-K., Kim, T.-J., Lee, J.-W., Kim, H.-J., Bae, D.-S., Kim, B.-G. (2012). Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival. Br J Cancer, 107, 91-99. [PubMed] [Google Scholar]
  • Choi, K.Y., Chang, K., Pickel, J.M., Badger, J.D., Roche, K.W. (2011). Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci, 108, 15219-15224. [CrossRef] [Google Scholar]
  • Cohen-Kaminsky, S., Hautefort, A., Price, L., Humbert, M., Perros, F. (2014).Inflammation in pulmonary hypertension: what we know and what we could logically and safely target first. Drug Discov Today, 19, 1251-1256. [CrossRef] [PubMed] [Google Scholar]
  • Courboulin, A., Paulin, R., Giguère, N.J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E.R., Biardel, S., Provencher, S., Cote, J., Simard, M.J., Bonnet, S. (2011). Role for miR-204 in human pulmonary arterial hypertension. J Exp Med, 208, 535-548. [CrossRef] [PubMed] [Google Scholar]
  • de Groot, J.F., Piao, Y., Lu, L., Fuller, G.N., Yung, W.K.A. (2008). Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol, 88, 121-133. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  • Doronzo, G., Russo, I., Del Mese, P., Viretto, M., Mattiello, L., Trovati, M., Anfossi, G. (2010). Role of NMDA receptor in homocysteine-induced activation of mitogen-activated protein kinase and phosphatidyl inositol 3-kinase pathways in cultured human vascular smooth muscle cells. Thromb Res, 125, e23-e32. [PubMed] [Google Scholar]
  • Drayton, R.M., Dudziec, E., Peter, S., Bertz, S., Hartmann, A., Bryant, H.E., Catto, J.W. (2014). Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11. Clin Cancer Res, 20, 1990-2000. [CrossRef] [PubMed] [Google Scholar]
  • Duong-Quy, S., Bei, Y., Liu, Z., Dinh-Xuan, A.T. (2013). Role of Rho-kinase and its inhibitors in pulmonary hypertension. Pharmacol Ther, 137, 352-364. [PubMed] [Google Scholar]
  • Elgadi, K.M., Meguid, R.A., Qian, M., Souba, W.W., Abcouwer, S.F. (1999). Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics, 1, 51-62. [CrossRef] [PubMed] [Google Scholar]
  • Erickson, J.W., Cerione, R.A. (2010). Glutaminase: A Hot Spot For Regulation Of Cancer Cell Metabolism? Oncotarget, 1, 734-740. [PubMed] [Google Scholar]
  • Esseltine, J.L., Willard, M.D., Wulur, I.H., Lajiness, M.E., Barber, T.D., Ferguson, S.S.G. (2013). Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling. Mol Pharmacol, 83, 770-780. [PubMed] [Google Scholar]
  • Evans, J.D.W., Girerd, B., Montani, D., Wang, X.-J., Galiè, N., Austin, E.D., Elliott, G., Asano, K., Grünig, E., Yan, Y., Jing, Z.-C., Manes, A., Palazzini, M., Wheeler, L.A., Nakayama, I., Satoh, T., Eichstaedt, C., Hinderhofer, K., Wolf; M., Rosenzweig, E.B., Chung, W.K., Soubrier, F., Simonneau, G., Sitbon, O., Gräf, S., Kaptoge, S., Di Angelantonio, E., Humbert, M., Morrell, N.W. (2016). BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Respir Med, 4, 129-137. [Google Scholar]
  • Fukumoto, Y., Yamada, N., Matsubara, H., Mizoguchi, M., Uchino, K., Yao, A., Kihara, Y., Kawano, M., Watanabe, H., Takeda, Y., Adachi, T., Osanai, S., Tanabe, N., Inoue, T., Kubo, A., Ota, Y., Fukuda, K., Nakano, T., Shimokawa, H. (2013). Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension. Circ J, 77, 2619-2625. [PubMed] [Google Scholar]
  • Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., Ghofrani, A., GomezSanchez, M.A., Hansmann, G., Klepetko, W., Lancellotti, P., Matucci, M., McDonagh, T., Pierard, L.A., Trindade, P.T., Zompatori, M., Hoeper, M. (2015). ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension. Eur Respir J, 46, 903-975. [CrossRef] [PubMed] [Google Scholar]
  • Ganor, Y., Grinberg, I., Reis, A., Cooper, I., Goldstein, R.S., Levite, D.M. (2009). Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo. Leuk Lymphoma, 50, 985-997. [PubMed] [Google Scholar]
  • George, M.P., Champion, H.C., Pilewski, J.M. (2011). Lung transplantation for pulmonary hypertension. Pulm Circ, 1, 182-191. [CrossRef] [PubMed] [Google Scholar]
  • Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem, 273, 30336-30343. [CrossRef] [PubMed] [Google Scholar]
  • Gillard, S.E., Tzaferis, J., Tsui, H.-C.T., Kingston, A.E. (2003). Expression of metabotropic glutamate receptors in rat meningeal and brain microvasculature and choroid plexus. J Comp Neurol, 461, 317-332. [PubMed] [Google Scholar]
  • Gill, S.S., Pulido, O.M. (2001). Glutamate Receptors in Peripheral Tissues: Current Knowledge, Future Research, and Implications for Toxicology. Toxicol Pathol, 29, 208-223. [CrossRef] [PubMed] [Google Scholar]
  • Gross, M.I., Demo, S.D., Dennison, J.B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J.R., Laidig, G.J., Lewis, E.R., Li, J., Mackinnon, A.L., Parlati, F., Rodriguez, M.L.M., Shwonek, P.J., Sjogren, E.B., Stanton, T.F., Wang, T., Yang, J., Zhao, F., Bennett, M.K. (2014). Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther, 13, 890-901. [CrossRef] [PubMed] [Google Scholar]
  • Guignabert, C., Tu, L., Izikki, M., Dewachter, L., Zadigue, P., Humbert, M., Adnot, S., Fadel, E., Eddahibi, S. (2009). Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22α-targeted overexpression of the serotonin transporter. FASEB J, 23, 4135-4147. [CrossRef] [PubMed] [Google Scholar]
  • Guignabert, C., Tu, L., Hiress, M.L., Ricard, N., Sattler, C., Seferian, A., Huertas, A., Humbert, M., Montani, D. (2013). Pathogenesis of pulmonary arterial hypertension: lessons from cancer. Eur Respir Rev, 22, 543-551. [CrossRef] [PubMed] [Google Scholar]
  • Hanahan, D., Weinberg, R.A. (2000). The hallmarks of cancer. Cell, 100, 57-70. [CrossRef] [PubMed] [Google Scholar]
  • Hanahan, D., Weinberg, R.A. (2011). Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [CrossRef] [PubMed] [Google Scholar]
  • Hasegawa, M., Takahashi, H., Rajabi, H., Alam, M., Suzuki, Y., Yin, L., Tagde, A., Maeda, T., Hiraki, M., Sukhatme, V.P., Kufe, D. (2016). Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget, 7, 11756-11769. [PubMed] [Google Scholar]
  • Hassanein, M., Hoeksema, M.D., Shiota, M., Qian, J., Harris, B.K., Chen, H., Clark, J.E., Alborn, W.E., Eisenberg, R., Massion, P.P. (2013). SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival. Clin Cancer Res, 19, 560-570. [CrossRef] [PubMed] [Google Scholar]
  • Hassanein, M., Qian, J., Hoeksema, M.D., Wang, J., Jacobovitz, M., Ji, X., Harris, F.T., Harris, B.K., Boyd, K.L., Chen, H., Eisenberg, R., Massion, P.P. (2015). Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer. Int J Cancer, 137, 1587-1597. [CrossRef] [PubMed] [Google Scholar]
  • Herner, A., Sauliunaite, D., Michalski, C.W., Erkan, M., Oliveira, T.D., Abiatari, I., Kong, B., Esposito, I., Friess, H., Kleeff, J. (2011). Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling. Int J Cancer, 129, 2349-2359. [CrossRef] [PubMed] [Google Scholar]
  • Herranz, D., Ambesi-Impiombato, A., Sudderth, J., Sánchez-Martín, M., Belver, L., Tosello, V., Xu, L., Wendorff, A.A., Castillo, M., Haydu, J.E., Márquez, J., Matés, J.M., Kung, A.L., Rayport, S., Cordon-Cardo, C., DeBerardinis, R.J., Ferrando, A.A. (2015). Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med, 21, 1182-1189. [CrossRef] [PubMed] [Google Scholar]
  • Hinoi, E., Takarada, T., Ueshima, T., Tsuchihashi, Y., Yoneda, Y. (2003). Glutamate signaling in peripheral tissues: Glutamate signaling in peripheral tissues. Eur J Biochem, 271, 1-13. [Google Scholar]
  • Hoeper, M.M., Lee, S.H., Voswinckel, R., Palazzini, M., Jais, X., Marinelli, A., Barst, R.J., Ghofrani, H.A., Jing, Z.-C., Opitz, C., Seyfarth, H.-J., Halank, M., McLaughlin, V., Oudiz, R.J., Ewert, R., Wilkens, H., Kluge, S., Bremer, H.-C., Baroke, E., Rubin, L.J. (2006). Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol, 48, 2546-2552. [CrossRef] [PubMed] [Google Scholar]
  • Hoeper, M.M., Barst, R.J., Bourge, R.C., Feldman, J., Frost, A.E., Galiè, N., Gómez-Sánchez, M.A., Grimminger, F., Grünig, E., Hassoun, P.M., Morrell, N.W., Peacock, A.J., Satoh, T., Simonneau, G., Tapson, V.F., Torres, F., Lawrence, D., Quinn, D.A., Ghofrani, H.-A. (2013). Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation, 127, 1128-1138. [CrossRef] [PubMed] [Google Scholar]
  • Huertas, A., Perros, F., Tu, L., Cohen-Kaminsky, S., Montani, D., Dorfmüller P.,Guignabert, C., Humbert, M. (2014). Immune Dysregulation and Endothelial Dysfunction in Pulmonary Arterial Hypertension A Complex Interplay. Circulation, 129, 1332-1340. [CrossRef] [PubMed] [Google Scholar]
  • Hu, H., Takano, N., Xiang, L., Gilkes, D.M., Luo, W., Semenza, G.L. (2014). Hypoxia-inducible factors enhance glutamate signaling in cancer cells. Oncotarget, 5, 8853. [PubMed] [Google Scholar]
  • Humbert, M. (2013). Impression, Sunset. Circulation, 127, 1098-1100. [CrossRef] [PubMed] [Google Scholar]
  • Humbert, M., Ghofrani, H.-A. (2016). The molecular targets of approved treatments for pulmonary arterial hypertension. Thorax, 71, 73-83. [CrossRef] [PubMed] [Google Scholar]
  • Humbert, M., Sitbon, O., Simonneau, G. (2004).Treatment of Pulmonary Arterial Hypertension. N Engl J Med, 351, 1425-1436. [CrossRef] [PubMed] [Google Scholar]
  • Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., Dromer, C., Pison; C., Reynaud-Gaubert, M., Haloun, A., Laurent, M., Hachulla, E., Cottin, V., Degano, B., Jaïs, X., Montani, D., Souza, R., Simonneau, G. (2010). Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation, 122, 156-163. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Iacovelli, L., Arcella, A., Battaglia, G., Pazzaglia, S., Aronica, E., Spinsanti, P., Caruso, A., De Smaele, E., Saran, A., Gulino, A., D’Onofrio, M., Giangaspero, F., Nicoletti, F. (2006). Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J Neurosci, 26, 8388-8397. [CrossRef] [PubMed] [Google Scholar]
  • Ibragimova, I., Slifker, M.J., Maradeo, M.E., Banumathy, G., Dulaimi, E., Uzzo, R.G., Cairns, P. (2013). Genome-Wide Promoter Methylome of Small Renal Masses. PLOS ONE, 8, e77309. [PubMed] [Google Scholar]
  • Ishiuchi, S., Tsuzuki, K., Yoshida, Y., Yamada, N., Hagimura, N., Okado, H., Miwa, A., Kurihara, H., Nakazato, Y., Tamura, M., Sasaki, T., Ozawa, S. (2002). Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med, 8, 971-978. [CrossRef] [PubMed] [Google Scholar]
  • Izikki, M., Hoang, E., Draskovic, I., Mercier, O., Lecerf, F., Lamrani, L., Liu, W.-Y., Guignabert, C., Fadel, E., Dorfmuller, P., Humbert, M., Londoño-Vallejo, A., Eddahibi, S. (2015). Telomere Maintenance Is a Critical Determinant in the Physiopathology of Pulmonary Hypertension. J Am Coll Cardiol, 66, 1942-1943. [CrossRef] [PubMed] [Google Scholar]
  • Jin, L., Alesi, G.N., Kang, S. (2016). Glutaminolysis as a target for cancer therapy. Oncogene, 35, 3619-3625. [CrossRef] [PubMed] [Google Scholar]
  • Julio-Pieper, M., Flor, P.J., Dinan, T.G., Cryan, J.F. (2011). Exciting Times beyond the Brain: Metabotropic Glutamate Receptors in Peripheral and Non-Neural Tissues. Pharmacol Rev, 63, 35-58. [CrossRef] [PubMed] [Google Scholar]
  • Kalariti, N., Lembessis, P., Koutsilieris, M. (2011). Characterization of the glutametergic system in MG-63 osteoblast-like osteosarcoma cells. Anticancer Res, 24, 3923-3929. [Google Scholar]
  • Kan, Z., Jaiswal, B.S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H.M., Yue, P., Haverty, P.M., Bourgon, R., Zheng, J., Moorhead, M., Chaudhuri, S., Tomsho, L.P., Peters, B.A., Pujara, K., Cordes, S., Davis, D.P., Carlton, V.E.H., Yuan, W., Li, L., Wang, W., Eigenbrot, C., Kaminker, J.S., Eberhard, D.A., Waring, P., Schuster, S.C., Modrusan, Z., Zhang, Z., Stokoe, D., de Sauvage, F.J., Faham, M., Seshagiri, S. (2010). Diverse somatic mutation patterns and pathway alterations in human cancers. Nature, 466, 869-873. [CrossRef] [PubMed] [Google Scholar]
  • Kasatkina, L.A., Borisova, T.A. (2013). Glutamate release from platelets: Exocytosis versus glutamate transporter reversal. Int J Biochem Cell Biol, 45, 2585-2595. [CrossRef] [PubMed] [Google Scholar]
  • Kim, M.S., Yamashita, K., Chae, Y.K., Tokumaru, Y., Chang, X., Zahurak, M., Osada, M., Park, H.L., Chuang, A., Califano, J.A., Sidransky, D. (2007). A Promoter Methylation Pattern in the N-Methyl-d-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma. Clin Cancer Res, 13, 6658-6665. [CrossRef] [PubMed] [Google Scholar]
  • Kim, M.S., Chang, X., Nagpal, J.K., Yamashita, K., Baek, J.H., Dasgupta, S., Wu, G., Osada, M., Woo, J.-H., Westra, W.H., Trink, B., Ratovitski, E.A., Moon, C., Sidransky, D. (2008). The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth. Oncogene, 27, 2045-2054. [CrossRef] [PubMed] [Google Scholar]
  • Koochekpour, S., Majumdar, S., Azabdaftari, G., Attwood, K., Scioneaux, R., Subramani, D., Manhardt, C., Lorusso, G.D., Willard, S.S., Thompson, H., Shourideh, M., Rezaei, K., Sartor, O., Mohler, J.L., Vessella, R.L. (2012). Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells. Clin Cancer Res, 18, 5888-5901. [CrossRef] [PubMed] [Google Scholar]
  • Koochekpour, S. (2013). Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. Asian J Androl, 15, 212-213. [PubMed] [Google Scholar]
  • Korczak, B., McWhinnie, E.A., Fletcher, E.J., Kamboj, R.K. (1995). Expression of human glutamate receptors (GluR) in neuroblastoma cell lines. Neuroreport, 6, 905-909. [CrossRef] [PubMed] [Google Scholar]
  • Krizbai, I.A., Deli, M.A., Pestenácz, A., Siklós, L., Szabó, C.A., András, I., Joó, F. (1998). Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res, 54, 814-819. [CrossRef] [PubMed] [Google Scholar]
  • Kuribayashi, N., Uchida, D., Kinouchi, M., Takamaru, N., Tamatani, T., Nagai, H., Miyamoto, Y. (2013). The Role of Metabotropic Glutamate Receptor 5 on the Stromal Cell-Derived Factor-1/CXCR4 System in Oral Cancer. PLoS ONE, 8, e80773. [PubMed] [Google Scholar]
  • Lang, I.M., Gaine, S.P. (2015). Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension. Eur Respir Rev, 24, 630-641. [CrossRef] [PubMed] [Google Scholar]
  • Lee, S.D., Shroyer, K.R., Markham, N.E., Cool, C.D., Voelkel, N.F., Tuder, R.M. (1998). Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest, 101, 927-934. [PubMed] [Google Scholar]
  • Le, M.N., Chan, J.L.-K., Rosenberg, S.A., Nabatian, A.S., Merrigan, K.T., Cohen-Solal, K.A., Goydos, J.S. (2010). The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells. J Invest Dermatol, 130, 2240-2249. [PubMed] [Google Scholar]
  • Liang, H., Cheung, L.W.T., Li, J., Ju, Z., Yu, S., Stemke-Hale, K., Dogruluk, T., Lu, Y., Liu, X., Gu, C., Guo, W., Scherer, S.E., Carter, H., Westin, S.N., Dyer, M.D., Verhaak, R.G.W., Zhang, F., Karchin, R., Liu, C.-G., Lu, K.H., Broaddus, R.R., Scott, K.L., Hennessy, B.T., Mills, G.B. (2012). Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res, 22, 2120-2129. [CrossRef] [PubMed] [Google Scholar]
  • Li, S., Qian, J., Yang, Y., Zhao, W., Dai, J., Bei, J.-X., Foo, J.N., McLaren, P.J., Li, Z., Yang, J., Shen, F., Liu, L., Yang, J., Li, S., Pan, S., Wang, Y., Li, W., Zhai, X., Zhou, B., Shi, L., Chen, X., Chu, M., Yan, Y., Wang, J., Cheng, S., Shen, J., Jia, W., Liu, J., Yang, J., Wen, Z., Li, A., Zhang, Y., Zhang, G., Luo, X., Qin, H., Chen, M., Wang, H., Jin, L., Lin, D., Shen, H., He, L., de Bakker, P.I.W., Wang, H., Zeng, Y.-X., Wu, M., Hu, Z., Shi, Y., Liu, J., Zhou, W. (2012). GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet, 8, e1002791. [CrossRef] [PubMed] [Google Scholar]
  • Li, L., Hanahan, D. (2013). Hijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion. Cell, 153, 86-100. [PubMed] [Google Scholar]
  • Liu, J.-W., Kim, M.S., Nagpal, J., Yamashita, K., Poeta, L., Chang, X., Lee, J., Park, H.L., Jeronimo, C., Westra, W.H., Mori, M., Moon, C., Trink, B., Sidransky, D. (2007). Quantitative hypermethylation of NMDAR2B in human gastric cancer. Int J Cancer, 121, 1994-2000. [CrossRef] [PubMed] [Google Scholar]
  • Luksch, H., Uckermann, O., Stepulak, A., Hendruschk, S., Marzahn, J., Bastian, S., Staufner, C., Temme, A., Ikonomidou, C. (2011). Silencing of Selected Glutamate Receptor Subunits Modulates Cancer Growth. Anticancer Res, 31, 3181-3192. [PubMed] [Google Scholar]
  • Lyons, S.A., Chung, W.J., Weaver, A.K., Ogunrinu, T., Sontheimer, H. (2007). Autocrine Glutamate Signaling Promotes Glioma Cell Invasion. Cancer Res, 67, 9463-9471. [Google Scholar]
  • Marín, Y.E., Chen, S. (2004). Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development. J Mol Med Berl Ger, 82, 735-749. [CrossRef] [MathSciNet] [Google Scholar]
  • Martino, J.J., Wall, B.A., Mastrantoni, E., Wilimczyk, B.J., La Cava, S.N., Degenhardt, K., White, E., Chen, S. (2013). Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells. Oncogene, 32, 4366-4376. [CrossRef] [PubMed] [Google Scholar]
  • McMurtry, M.S., Bonnet, S., Wu, X., Dyck, J.R.B., Haromy, A., Hashimoto, K., Michelakis, E.D. (2004). Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis. Circ Res, 95, 830-840. [Google Scholar]
  • McMurtry, M.S., Moudgil, R., Hashimoto, K., Bonnet, S., Michelakis, E.D., Archer, S.L. (2007). Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension. Am J Physiol - Lung Cell Mol Physiol, 292, L872-L878. [CrossRef] [Google Scholar]
  • Mehta, M.S., Dolfi, S.C., Bronfenbrener, R., Bilal, E., Chen, C., Moore, D., Lin, Y., Rahim, H., Aisner, S., Kersellius, R.D., Teh, J., Chen, S., Toppmeyer, D.L., Medina, D.J., Ganesan, S., Vazquez, A., Hirshfield, K.M. (2013). Metabotropic Glutamate Receptor 1 Expression and Its Polymorphic Variants Associate with Breast Cancer Phenotypes. PLoS ONE, 8, e69851. [PubMed] [Google Scholar]
  • Meloche, J., Pflieger, A., Vaillancourt, M., Paulin, R., Potus, F., Zervopoulos, S., Graydon, C., Courboulin, A., Breuils-Bonnet, S., Tremblay, E., Couture, C., Michelakis, E.D., Provencher, S., Bonnet, S. (2014). Role for DNA damage signaling in pulmonary arterial hypertension. Circulation, 129, 786-797. [CrossRef] [PubMed] [Google Scholar]
  • Michelakis, E.D., McMurtry, M.S., Wu, X.-C., Dyck, J.R.B., Moudgil, R., Hopkins, T.A., Lopaschuk, G.D., Puttagunta, L., Waite, R., Archer, S.L. (2002). Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation, 105, 244-250. [CrossRef] [PubMed] [Google Scholar]
  • Mizuno, S., Bogaard, H.J., Kraskauskas, D., Alhussaini, A., Gomez-Arroyo, J., Voelkel, N.F., Ishizaki, T. (2011). p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol-Lung Cell Mol Physiol, 300, L753-761. [CrossRef] [Google Scholar]
  • Montani, D., Perros, F., Gambaryan, N., Girerd, B., Dorfmuller, P., Price, L.C., Huertas, A., Hammad, H., Lambrecht, B., Simonneau, G., Launay, J.M., Cohen-Kaminsky, S., Humbert, M. (2011). C-Kit-Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension. Am J Respir Crit Care Med, 184, 116-23. [CrossRef] [PubMed] [Google Scholar]
  • Morimoto, R., Uehara, S., Yatsushiro, S., Juge, N., Hua, Z., Senoh, S., Echigo, N., Hayashi, M., Mizoguchi, T., Ninomiya, T., Udagawa, N., Omote, H., Yamamoto, A., Edwards, R.H., Moriyama, Y. (2006). Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J, 25, 4175-4186. [PubMed] [Google Scholar]
  • Moriyama, Y., Yamamoto, A. (2004). Glutamatergic Chemical Transmission: Look! Here, There, and Anywhere. J Biochem (Tokyo), 135, 155-163. [CrossRef] [Google Scholar]
  • Morrison, C.D., Liu, P., Woloszynska-Read, A., Zhang, J., Luo, W., Qin, M., Bshara, W., Conroy, J.M., Sabatini, L., Vedell, P., Xiong, D., Liu, S., Wang, J., Shen, H., Li, Y., Omilian, A.R., Hill, A., Head, K., Guru, K., Kunnev, D., Leach, R., Eng, K.H., Darlak, C., Hoeflich, C., Veeranki, S., Glenn, S., You, M., Pruitt, S.C., Johnson, C.S., Trump, D.L. (2014). Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer. Proc Natl Acad Sci USA, 111, E672-E681. [CrossRef] [Google Scholar]
  • Mouraret, N., Marcos, E., Abid, S., Gary-Bobo, G., Saker, M., Houssaini, A., Dubois-Rande, J.-L., Boyer, L., Boczkowski, J., Derumeaux, G., Amsellem, V., Adnot, S. (2013). Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension. Circulation, 127, 1664-1676. [CrossRef] [PubMed] [Google Scholar]
  • Mouraret, N., Houssaïni, A., Abid, S., Quarck, R., Marcos, E., Parpaleix, A., Gary-Bobo, G., Dubois-Randé, J.-L., Derumeaux, G., Boczkowski, J., Delcroix, M., Blasco, M.A., Lipskaia, L., Amsellem, V., Adnot, S. (2015). Role for telomerase in pulmonary hypertension. Circulation, 131, 742-755. [CrossRef] [PubMed] [Google Scholar]
  • Naarala, J., Nykvist, P., Tuomala, M., Savolainen, K.V. (1993). Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells. FEBS Lett, 330, 222-226. [CrossRef] [PubMed] [Google Scholar]
  • Namkoong, J., Shin, S.-S., Lee, H.J., Marín, Y.E., Wall, B.A., Goydos, J.S., Chen, S. (2007). Metabotropic Glutamate Receptor 1 and Glutamate Signaling in Human Melanoma. Cancer Res, 67, 2298-2305. [Google Scholar]
  • North, W.G., Gao, G., Jensen, A., Memoli, V.A., Du, J. (2010a). NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment. Clin Pharmacol Adv Appl, 2, 31-40. [Google Scholar]
  • North, W.G., Gao, G., Memoli, V.A., Pang, R.H., Lynch, L. (2010b). Breast cancer expresses functional NMDA receptors. Breast Cancer Res Treat, 122, 307-314. [CrossRef] [PubMed] [Google Scholar]
  • North, W., Liu, F., Tian, R., Abbasi, H., Akerman, B. (2015). NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines. Clin Pharmacol Adv Appl, 7, 111-117. [Google Scholar]
  • O’Callaghan, D.S., Savale, L., Montani, D., Jaïs, X., Sitbon, O., Simonneau, G., Humbert, M. (2011). Treatment of pulmonary arterial hypertension with targeted therapies. Nat Rev Cardiol, 8, 526-538. [CrossRef] [PubMed] [Google Scholar]
  • Ohkuma, S., Katsura, M., Chen, D.Z., Chen, S.H., Kuriyama, K. (1994). Presence of N-methyl-D-aspartate (NMDA) receptors in neuroblastoma x glioma hybrid NG108-15 cells-analysis using [45Ca2+]influx and [3H]MK-801 binding as functional measures. Brain Res Mol Brain Res, 22, 166-172. [CrossRef] [PubMed] [Google Scholar]
  • Ohtani, Y., Harada, T., Funasaka, Y., Nakao, K., Takahara, C., Abdel-Daim, M., Sakai, N., Saito, N., Nishigori, C., Aiba, A. (2008). Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma. Oncogene, 27, 7162-7170. [CrossRef] [PubMed] [Google Scholar]
  • Park, S.-Y., Lee, S.-A., Han, I.-H., Yoo, B.-C., Lee, S.-H., Park, J.-Y., Cha, I.-H., Kim, J., Choi, S.-W. (2007). Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep, 17, 81-87. [PubMed] [Google Scholar]
  • Paulin, R., Michelakis, E.D. (2014). The metabolic theory of pulmonary arterial hypertension. Circ Res, 115, 148-164. [Google Scholar]
  • Perrin, S., Chaumais, M.-C., O’Connell, C., Amar, D., Savale, L., Jaïs, X., Montani, D., Humbert, M., Simonneau, G., Sitbon, O. (2015). New pharmacotherapy options for pulmonary arterial hypertension. Expert Opin Pharmacother, 16, 2113-2131. [CrossRef] [PubMed] [Google Scholar]
  • Perros,, F., Montani,, D., Dorfmüller, P., Durand-Gasselin, I., Tcherakian, C., Le Pavec, J., Mazmanian, M., Fadel, E., Mussot, S., Mercier, O., Hervé, P., Emilie, D., Eddahibi, S., Simonneau, G., Souza, R., Humbert, M. (2008). Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med, 178, 81-88. [CrossRef] [PubMed] [Google Scholar]
  • Perros, F., Dorfmüller, P., Montani, D., Hammad, H., Waelput, W., Girerd, B., Raymond, N., Mercier, O., Mussot, S., Cohen-Kaminsky, S., Humbert, M., Lambrecht, B.N. (2012). Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med, 185, 311-321. [CrossRef] [PubMed] [Google Scholar]
  • Piao, L., Fang, Y.-H., Parikh, K., Ryan, J.J., Toth, P.T., Archer, S.L. (2013). Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension. J Mol Med Berl Ger, 91, 1185-1197. [CrossRef] [Google Scholar]
  • Pissimissis, N., Papageorgiou, E., Lembessis, P., Armakolas, A., Koutsilieris, M. 2009. The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells. Anticancer Res, 29, 371-377. [PubMed] [Google Scholar]
  • Pollock, P.M., Cohen-Solal, K., Sood, R., Namkoong, J., Martino, J.J., Koganti, A., Zhu,, H., Robbins, C., Makalowska, I., Shin, S.-S., Marin, Y., Roberts, K.G., Yudt, L.M., Chen, A., Cheng, J., Incao, A., Pinkett, H.W., Graham, C.L., Dunn, K., Crespo-Carbone, S.M., Mackason, K.R., Ryan, K.B., Sinsimer, D., Goydos, J., Reuhl, K.R., Eckhaus, M., Meltzer, P.S., Pavan, W.J., Trent, J.M., Chen, S. (2003). Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet, 34, 108-112. [CrossRef] [PubMed] [Google Scholar]
  • Prickett, T.D., Samuels, Y. (2012). Molecular pathways: dysregulated glutamatergic signaling pathways in cancer. Clin Cancer Res, 18, 4240-4246. [CrossRef] [PubMed] [Google Scholar]
  • Prickett, T.D., Wei, X., Cardenas-Navia, I., Teer, J.K., Lin, J.C., Walia, V., Gartner, J., Jiang, J., Cherukuri, P.F., Molinolo, A., Davies, M.A., Gershenwald J.E., Stemke-Hale, K., Rosenberg, S.A., Margulies, E.H., Samuels, Y. (2011). Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet, 43, 1119-1126. [CrossRef] [PubMed] [Google Scholar]
  • Qureshi, I., Chen, H., Brown, A.T., Fitzgerald, R., Zhang, X., Breckenridge, J., Kazi, R., Crocker, A.J., Stühlingexsr, M.C., Lin, K., Cooke, J.P., Eidt, J.F., Moursi, M.M. (2005). Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Vasc Med, 10, 215-223. [CrossRef] [PubMed] [Google Scholar]
  • Rabinovitch, M., Guignabert, C., Humbert, M., Nicolls, M.R. (2014). Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension. Circ Res, 115, 165-175. [Google Scholar]
  • Rai, P.R., Cool, C.D., King, J.A.C., Stevens, T., Burns, N., Winn, R.A., Kasper, M., Voelkel, N.F. (2008). The Cancer Paradigm of Severe Pulmonary Arterial Hypertension. Am J Respir Crit Care Med, 178, 558-564. [CrossRef] [PubMed] [Google Scholar]
  • Ranchoux, B., Antigny, F., Rucker-Martin, C., Hautefort, A., Péchoux, C., Bogaard, H.J., Dorfmüller, P., Remy, S., Lecerf, F., Planté S., Chat, S., Fadel, E., Houssaini, A., Anegon, I., Adnot, S., Simonneau, G., Humbert, M., Cohen-Kaminsky, S., Perros, F. (2015). Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation, 131, 1006-1018. [CrossRef] [PubMed] [Google Scholar]
  • Redecker, P., Kreutz, M.R., Bockmann, J., Gundelfinger, E.D., Boeckers, T.M. (2003). Brain Synaptic Junctional Proteins at the Acrosome of Rat Testicular Germ Cells. J Histochem Cytochem, 51, 809-819. [CrossRef] [PubMed] [Google Scholar]
  • Ripka, S., Riedel, J., Neesse, A., Griesmann, H., Buchholz, M., Ellenrieder, V., Moeller, F., Barth, P., Gress, T.M., Michl, P. (2010). Glutamate Receptor GRIA3–Target of CUX1 and Mediator of Tumor Progression in Pancreatic Cancer. Neoplasia NYN, 12, 659-667. [CrossRef] [Google Scholar]
  • Rzeski, W., Turski, L., Ikonomidou, C. (2001). Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA, 98, 6372-6377. [CrossRef] [Google Scholar]
  • Savage, S.A., Mirabello, L., Wang, Z., Gastier-Foster, J.M., Gorlick, R., Khanna, C., Flanagan, A.M., Tirabosco, R., Andrulis, I.L., Wunder, J.S., Gokgoz, N., Patiño-Garcia, A., Sierrasesúmaga, L., Lecanda, F., Kurucu, N., Ilhan, I.E., Sari, N., Serra, M., Hattinger, C., Picci, P., Spector, L.G., Barkauskas, D.A., Marina, N., de Toledo, S.R.C., Petrilli, A.S., Amary, M.F., Halai, D., Thomas, D.M., Douglass, C., Meltzer, P.S., Jacobs, K., Chung, C.C., Berndt, S.I., Purdue, M.P., Caporaso, N.E., Tucker, M., Rothman, N., Landi, M.T., Silverman, D.T., Kraft, P., Hunter, D.J., Malats, N., Kogevinas, M., Wacholder, S., Troisi, R., Helman, L., Fraumeni, J.F., Yeager, M., Hoover, R.N., Chanock, S.J. (2013). Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet, 45, 799-803. [CrossRef] [PubMed] [Google Scholar]
  • Schermuly, R.T., Dony, E., Ghofrani, H.A., Pullamsetti, S., Savai, R., Roth, M., Sydykov, A., Lai, Y.J., Weissmann, N., Seeger, W., Grimminger, F. (2005). Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest, 115, 2811-2821. [PubMed] [Google Scholar]
  • Sharma, M.K., Seidlitz, E.P., Singh, G. (2010). Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem Biophys Res Commun, 391, 91-95. [CrossRef] [PubMed] [Google Scholar]
  • Sinclair, P.B., Sorour, A., Martineau, M., Harrison, C.J., Mitchell, W.A., O’Neill, E., Foroni, L. (2004). A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene. Cancer Res, 64, 4089-4098. [Google Scholar]
  • Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E.A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., Montani, D., Humbert, M., Simonneau, G. (2014a). Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. Eur Respir J, 43, 1691-1697. [PubMed] [Google Scholar]
  • Sitbon, O., Savale, L., Jaïs, X., Montani, D., Humbert, M., Simonneau, G. (2014b). Traitement de l’hypertension artérielle pulmonaire. Presse Médicale, 43, 981-993. [CrossRef] [Google Scholar]
  • Soria, F.N., Pérez-Samartín, A., Martin, A., Gona, K.B., Llop, J., Szczupak, B., Chara, J.C., Matute, C., Domercq, M. (2014). Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. J Clin Invest, 124, 3645-3655. [PubMed] [Google Scholar]
  • Speyer, C.L., Smith, J.S., Banda, M., DeVries, J.A., Mekani, T., Gorski, D.H. 2011. Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat, 132, 565-573. [CrossRef] [PubMed] [Google Scholar]
  • Stepulak, A., Sifringer, M., Rzeski, W., Endesfelder, S., Gratopp, A., Pohl, E.E., Bittigau, P., Felderhoff-Mueser, U., Kaindl, A.M., Bührer, C., Hansen, H.H., Stryjecka-Zimmer, M., Turski, L., Ikonomidou, C. (2005). NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA, 102, 15605-15610. [CrossRef] [Google Scholar]
  • Stepulak, A., Luksch, H., Gebhardt, C., Uckermann, O., Marzahn, J., Sifringer, M., Rzeski, W., Staufner, C., Brocke, K.S., Turski, L., Ikonomidou, C. (2009). Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol, 132, 435-445. [CrossRef] [PubMed] [Google Scholar]
  • Stepulak, A., Luksch, H., Uckermann, O., Sifringer, M., Rzeski, W., Polberg, K., Kupisz, K., Klatka, J., Kiełbus, M., Grabarska, A., Marzahn, J., Turski, L., Ikonomidou, C. (2011). Glutamate Receptors in Laryngeal Cancer Cells. Anticancer Res, 31, 565-573. [PubMed] [Google Scholar]
  • Takano, T., Lin, J.H.-C., Arcuino, G., Gao, Q., Yang, J., Nedergaard, M. (2001). Glutamate release promotes growth of malignant gliomas. Nat Med, 7, 1010-1015. [CrossRef] [PubMed] [Google Scholar]
  • Tamura, H., Suzuki, M., Moriya, Y., Hoshino, H., Okamoto, T., Yoshida, S., Yoshino, I. (2011). Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma. BMC Cancer, 11, 220. [CrossRef] [PubMed] [Google Scholar]
  • Tanaka, K., Sasayama, T., Irino, Y., Takata, K., Nagashima, H., Satoh, N., Kyotani, K., Mizowaki, T., Imahori, T., Ejima, Y., Masui, K., Gini, B., Yang, H., Hosoda, K., Sasaki, R., Mischel, P.S., Kohmura, E. (2015). Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J Clin Invest, 125, 1591-1602. [PubMed] [Google Scholar]
  • Tremolizzo, L., DiFrancesco, J.C., Rodriguez-Menendez, V., Sirtori, E., Longoni, M., Cassetti, A., Bossi, M., El Mestikawy, S., Cavaletti, G., Ferrarese, C. (2006). Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation. Neurosci Lett, 404, 262-265. [CrossRef] [PubMed] [Google Scholar]
  • Tuder, R.M., Chacon, M., Alger, L., Wang, J., Taraseviciene-Stewart, L., Kasahara, Y., Cool, C.D., Bishop, A.E., Geraci, M., Semenza, G.L., Yacoub, M., Polak, J.M., Voelkel, N.F. (2001). Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol, 195, 367-374. [PubMed] [Google Scholar]
  • Tu, L., Dewachter, L., Gore, B., Fadel, E., Dartevelle, P., Simonneau, G., Humbert, M., Eddahibi, S., Guignabert, C. (2011). Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am J Respir Cell Mol Biol, 45, 311-322. [CrossRef] [PubMed] [Google Scholar]
  • Wang, J.-B., Erickson, J.W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K.F., Ambrosio, A.L.B., Dias, S.M.G., Dang, C.V., Cerione, R.A. (2010). Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation. Cancer Cell, 18, 207-219. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Wang, Q., Beaumont, K.A., Otte, N.J., Font, J., Bailey, C.G., van Geldermalsen, M., Sharp, D.M., Tiffen, J.C., Ryan, R.M., Jormakka, M., Haass, N.K., Rasko, J.E.J., Holst, J. (2014). Targeting glutamine transport to suppress melanoma cell growth. Int J Cancer, 135, 1060-1071. [CrossRef] [PubMed] [Google Scholar]
  • Watanabe, K., Kanno, T., Oshima, T., Miwa, H., Tashiro, C., Nishizaki, T. (2008). The NMDA receptor NR2A subunit regulates proliferation of MKN45 human gastric cancer cells. Biochem Biophys Res Commun, 367, 487-490. [CrossRef] [PubMed] [Google Scholar]
  • Wei, X., Walia, V., Lin, J.C., Teer, J.K., Prickett, T.D., Gartner, J., Davis, S., NISC Comparative Sequencing Program,Stemke-Hale, K., Davies, M.A., Gershenwald, J.E., Robinson, W., Robinson, S., Rosenberg, S.A., Samuels, Y. (2011). Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet, 43, 442-446. [CrossRef] [PubMed] [Google Scholar]
  • Willard, S.S., Koochekpour, S. (2013). Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications. Int J Biol Sci, 9, 728-742. [CrossRef] [PubMed] [Google Scholar]
  • Willems, L., Jacque, N., Jacquel, A., Neveux, N., Trovati Maciel, T., Lambert, M., Schmitt, A., Poulain, L., Green, A.S., Uzunov, M., Kosmider, O., Radford-Weiss, I., Moura, I.C., Auberger, P., Ifrah, N., Bardet, V., Chapuis, N., Lacombe, C., Mayeux, P., Tamburini, J., Bouscary, D. (2013). Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood, 122, 3521-3532. [Google Scholar]
  • Wise, D.R., Thompson, C.B. (2010). Glutamine Addiction: A New Therapeutic Target in Cancer. Trends Biochem Sci, 35, 427-433. [CrossRef] [PubMed] [Google Scholar]
  • Wu, C.-S., Lu, Y.-J., Li, H.-P., Hsueh, C., Lu, C.-Y., Leu, Y.-W., Liu, H.-P., Lin, K.-H., Hui-Ming Huang, T., Chang, Y.-S. (2010). Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer, 126, 2542-2552. [PubMed] [Google Scholar]
  • Xiang, Y., Stine, Z.E., Xia, J., Lu, Y., O’Connor, R.S., Altman, B.J., Hsieh, A.L., Gouw, A.M., Thomas, A.G., Gao, P., Sun, L., Song, L., Yan, B., Slusher, B.S., Zhuo, J., Ooi, L.L., Lee, C.G.L., Mancuso, A., McCallion, A.S., Le, A., Milone, M.C., Rayport, S., Felsher, D.W., Dang, C.V. (2015). Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest, 125, 2293-2306. [PubMed] [Google Scholar]
  • Xu, W., Koeck, T., Lara, A.R., Neumann, D., DiFilippo, F.P., Koo, M., Janocha, A.J., Masri, F.A., Arroliga, A.C., Jennings, C., Dweik, R.A., Tuder, R.M., Stuehr, D.J., Erzurum, S.C. (2007). Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci USA, 104, 1342-1347. [CrossRef] [Google Scholar]
  • Yamada, H., Otsuka, M., Hayashi, M., Nakatsuka, S., Hamaguchi, K., Yamamoto, A., Moriyama, Y. (2001). Ca2+-dependent exocytosis of L-glutamate by alphaTC6, clonal mouse pancreatic alpha-cells. Diabetes, 50, 1012-1020. [PubMed] [Google Scholar]
  • Yamaguchi, F., Hirata, Y., Akram, H., Kamitori, K., Dong, Y., Sui, L., Tokuda, M. 2013. FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer, 13, 468. [CrossRef] [PubMed] [Google Scholar]
  • Yeager, M.E., Halley, G.R., Golpon, H.A., Voelkel, N.F., Tuder, R.M. (2001). Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res, 88, E2-E11. [Google Scholar]
  • Yoo, B.C., Jeon, E., Hong, S.-H., Shin, Y.-K., Chang, H.J., Park, J.-G. (2004). Metabotropic Glutamate Receptor 4-Mediated 5-Fluorouracil Resistance in a Human Colon Cancer Cell Line. Clin Cancer Res, 10, 4176-4184. [CrossRef] [PubMed] [Google Scholar]
  • Yoshioka, A., Ikegaki, N., Williams, M., Pleasure, D. (1996). Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines. J Neurosci Res, 46, 164-178. [CrossRef] [PubMed] [Google Scholar]
  • Yu, L.J., Wall, B.A., Wangari-Talbot, J., Chen, S. (2016).Metabotropic glutamate receptors in cancer. Neuropharmacology, doi:10.1016/j.neuropharm.2016.02.011. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.